Dr. Hui-Ming Chang is a professor in the College of Medicine's departments of pharmacology/toxicology and internal medicine at the University of Arkansas for Medical Sciences in Little Rock. She's conducting an inaugural phase 1 clinical trial at the newly opened Winthrop P. Rockefeller Cancer Institute researching methods to reduce chemotherapy cardiotoxicity.
UAMS Researcher Aims to Reduce Chemotherapy Cardio Toxicity
Facebook Twitter LinkedIn Email
Your browser doesn’t support HTML5 audio